Morphine Sulfate Injection Recalled for Lack of Sterility Assurance
Nephron Sterile Compounding Center is recalling Morphine Sulfate Injection syringes distributed nationwide due to lack of assurance of sterility. Approximately 43,385 syringes are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves an injectable medication where sterility assurance is critical. Although sterility failures in injectables pose a serious potential health risk, no illnesses or adverse events have been reported, placing this in the risk-of-harm category without documented injury.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Morphine Sulfate Injection, USP, 2 mg/2 mL (1 mg/mL) pre-filled syringes distributed nationwide in the United States. Approximately 43,385 syringes are affected by this recall.
The recall was initiated due to lack of assurance of sterility. The affected lot numbers and expiration dates are: MS2001A (Exp. 7/2/2022), MS2006A (Exp. 8/9/2022), MS2009A (Exp. 8/25/2022), MS2011A (Exp. 9/3/2022), and MS2017A (Exp. 10/2/2022). This is a prescription-only product from Nephron's 503B outsourcing facility.
No illnesses or adverse events have been reported in association with this recall. Healthcare providers and patients should contact their healthcare provider or pharmacist if they have questions about medication from the affected lots.
The recalled product
- Product
- Morphine Sulfate Injection, USP, 2 mg/2 mL (1 mg/mL) syringe, packaged in 5 x 2 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-979-02
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Pre-filled Syringe
- Hazard
- Affected units
- 43,385
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lots: MS2001A
- Exp. 7/2/2022
- MS2006A
- Exp. 8/9/2022
- MS2009A
- Exp. 8/25/2022
- MS2011A
- Exp. 9/3/2022
- MS2017A
- Exp. 10/2/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 37 recalled by Nephron Sterile Compounding Center LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Nephron Sterile Compounding Center LLC
See all →- HighSodium Chloride Injection Recalled for Potential Sterility Compromise
FDA (Drugs) · 2025-03-19
- HighNorepinephrine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighNephron Phenylephrine HCl Injection Recalled for Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighDiltiazem HCl Injectable Drug Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-03-08
- HighFDA Recalls Norepinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2023-03-08
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22